WO2018080396A3 - Compounds and methods to target a molecule to a specific cellular location - Google Patents

Compounds and methods to target a molecule to a specific cellular location Download PDF

Info

Publication number
WO2018080396A3
WO2018080396A3 PCT/SG2017/050533 SG2017050533W WO2018080396A3 WO 2018080396 A3 WO2018080396 A3 WO 2018080396A3 SG 2017050533 W SG2017050533 W SG 2017050533W WO 2018080396 A3 WO2018080396 A3 WO 2018080396A3
Authority
WO
WIPO (PCT)
Prior art keywords
molecule
compounds
target
methods
specific cellular
Prior art date
Application number
PCT/SG2017/050533
Other languages
French (fr)
Other versions
WO2018080396A2 (en
Inventor
Shenquan Pan
Xiaoyang Li
Original Assignee
National University Of Singapore
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National University Of Singapore filed Critical National University Of Singapore
Priority to CN201780065902.5A priority Critical patent/CN110036021B/en
Publication of WO2018080396A2 publication Critical patent/WO2018080396A2/en
Publication of WO2018080396A3 publication Critical patent/WO2018080396A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

This invention relates to a peptide comprising or consisting of (i) the amino acid sequence of SEQ ID NO:1 or (ii) an amino acid sequence having at least 80% sequence identity to the amino acid sequence of SEQ ID NO:1 over its entire length. The present invention also relates to a conjugate, a host cell, a bio-imaging system, a method to visualize internalization, a method to internalize a drug into a cell and the conjugate of the invention for use as a medicament or the use of the conjugate of the invention as a research agent.
PCT/SG2017/050533 2016-10-24 2017-10-24 Compounds and methods to target a molecule to a specific cellular location WO2018080396A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201780065902.5A CN110036021B (en) 2016-10-24 2017-10-24 Compounds and methods for targeting molecules to specific cellular locations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SG10201608928QA SG10201608928QA (en) 2016-10-24 2016-10-24 Compounds and methods to target a molecule to a specific cellular location
SG10201608928Q 2016-10-24

Publications (2)

Publication Number Publication Date
WO2018080396A2 WO2018080396A2 (en) 2018-05-03
WO2018080396A3 true WO2018080396A3 (en) 2018-09-27

Family

ID=62025316

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SG2017/050533 WO2018080396A2 (en) 2016-10-24 2017-10-24 Compounds and methods to target a molecule to a specific cellular location

Country Status (3)

Country Link
CN (1) CN110036021B (en)
SG (1) SG10201608928QA (en)
WO (1) WO2018080396A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060037099A1 (en) * 2002-11-20 2006-02-16 Stefan Werner Method of controlling gene expression in plants or plant cells
US20090271896A1 (en) * 2006-08-07 2009-10-29 Ajith Anand Method for agrobacterium-mediated transformation of plants

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060037099A1 (en) * 2002-11-20 2006-02-16 Stefan Werner Method of controlling gene expression in plants or plant cells
US20090271896A1 (en) * 2006-08-07 2009-10-29 Ajith Anand Method for agrobacterium-mediated transformation of plants

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE Protein [O] 26 May 2015 (2015-05-26), XP055547849, retrieved from NCBI Database accession no. WP_012478091.1 *
LI, XIAOYANG ET AL.: "Agrobacterium delivers VirE2 protein into host cells via clathrin-mediated endocytosis", SCIENCE ADVANCES, vol. 3, no. 3, 22 March 2017 (2017-03-22), pages e1601528, XP055547852 *
LI, XIAOYANG ET AL.: "Direct visualization of Agrobacterium-delivered VirE2 in recipient cells", THE PLANT JOURNAL, vol. 77, no. 3, 16 January 2014 (2014-01-16), pages 487 - 495, XP055509100 *
SAKALIS, PHILIPPE A. ET AL.: "Visualization of VirE2 protein translocation by the Agrobacterium type IV secretion system into host cells", MICROBIOLOGYOPEN, vol. 3, no. 1, February 2014 (2014-02-01), pages 104 - 117, XP055547846 *

Also Published As

Publication number Publication date
CN110036021A (en) 2019-07-19
SG10201608928QA (en) 2018-05-30
CN110036021B (en) 2023-04-11
WO2018080396A2 (en) 2018-05-03

Similar Documents

Publication Publication Date Title
MX2019006045A (en) Psma targeting trispecific proteins and methods of use.
PH12020500231A1 (en) Interleukin-21 muteins and methods of treatment
MX2017014908A (en) Trispecific binding proteins and methods of use.
WO2018191502A3 (en) Anti-cd137 antibodies and methods of use thereof
MX2019000566A (en) Ev-mediated delivery of binding protein-small molecule conjugates.
MX2012008999A (en) Pharmaceutical composition for treatment and/or prevention of cancer.
MX340015B (en) Pharmaceutical composition for treatment and/or prevention of cancer.
MX342291B (en) Pharmaceutical composition for treatment and/or prevention of cancer.
MX340016B (en) Pharmaceutical composition for treatment and/or prevention of cancer.
MX360208B (en) Pharmaceutical composition for treatment and/or prevention of cancer.
WO2015051199A3 (en) Modified pseudomonas exotoxin a
MX360211B (en) Pharmaceutical composition for treatment and/or prevention of cancer.
MX363136B (en) Pharmaceutical composition for treatment and/or prevention of cancer.
CL2019003409A1 (en) Isolated tumor associated peptide (tumap); nucleic acid; expression vector; recombinant host cell comprising the peptide; method of producing the peptide; use to prepare a rare useful drug to treat cancer; pharmaceutical kit. (divisional request 201702407)
EP4269562A3 (en) Antigen binding molecules and methods of use thereof
WO2016130628A8 (en) Griffithsin mutants
MX2011007963A (en) Neil3 peptides and vaccines including the same.
WO2015107363A3 (en) Mycobacterial antigen composition
WO2018202921A3 (en) Nanostructured proteins and uses thereof
IN2014DN09963A (en)
MX355759B (en) Topk peptides and vaccines including the same.
MX2017013480A (en) Pharmaceutical composition for treating and/or preventing cancer.
CA2819463C (en) Tomm34 peptides and vaccines including the same
EP3868778A3 (en) Cdc45l peptides and vaccines including the same
WO2018080396A3 (en) Compounds and methods to target a molecule to a specific cellular location

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17864553

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17864553

Country of ref document: EP

Kind code of ref document: A2